Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $132.5500 (0.45%) ($131.5800 - $134.6900) on Fri. Jul. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.89% (three month average) | RSI | 69 | Latest Price | $132.5500(0.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.945% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.945% (StdDev 1.89%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $130.74(1.38%) | 10 Day Moving Average | $128.98(2.77%) | 20 Day Moving Average | $124.84(6.18%) | To recent high | -1.9% | To recent low | 18.6% | Market Cap | $2.13b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |